Data Integrity & Digital Pharma Operations – Page 17

Unapproved retest workflows in LIMS specification management: Data Integrity Risks and Corrective Controls

The symptoms of LIMS data integrity issues can manifest in several ways, potentially leading to serious compliance risks. In our case study, the following signals were noted:Click to read the…

Step-by-Step Guide to Managing Chromatogram Reprocessing After OOS Under ALCOA+ Expectations

Identifying the symptoms of chromatogram integrity issues begins with vigilant monitoring of results and processes. Common signals that indicate potential data integrity breaches in chromatography data systems include:Click to read…

How to Prepare Chromatography Systems for Data Integrity Inspection Review

Identifying failure signals is the first step toward ensuring data integrity during inspections. Here are some common symptoms associated with chromatography systems:Click to read the full article.

Unapproved retest workflows in LIMS stability sample pulls: Data Integrity Risks and Corrective Controls

Awareness of the symptoms indicating unapproved retest workflows is critical to mitigate data integrity risks in your quality control processes. Symptoms may include:Click to read the full article.

How to Prevent CDS User Role Conflicts in CDS (Chromatography Data System) Risks

The initial signs of user role conflicts in a CDS platform can be subtle yet impactful. Here are some common symptoms to be vigilant about:Click to read the full article.

Data Integrity Walkthroughs: What Inspectors Check on the Shop Floor

Detecting symptoms that indicate data integrity issues is crucial for early intervention. Some of the most common signals include:Click to read the full article.

Missing chain-of-custody links in LIMS sample login and accessioning: Data Integrity Risks and Corrective Controls

Identifying the symptoms of LIMS data integrity issues is the first step in addressing potential failures in the sample management process. Common signals that may indicate missing chain-of-custody links include:Click…

Missing Raw Data Links: Root Causes, GMP Risks, and CAPA Controls

The first step to addressing CDS data integrity risks is to identify indicators of potential failures, such as missing raw data links. Common symptoms may include:Click to read the full…

How to Explain Audit Trail Review Frequency During GMP Inspections

Before diving into solutions, it’s vital to identify the symptoms that may indicate insufficient audit trail review practices. Look for:Click to read the full article.

Missing chain-of-custody links in LIMS test assignment workflows: Data Integrity Risks and Corrective Controls

Recognizing early symptoms of LIMS data integrity issues is critical for timely intervention. Here are some common signs that may suggest there are flaws in your test assignment workflows:Click to…

Inspection-Ready Approach to Electronic Signature Weaknesses in Pharmaceutical Operations

The first step in addressing electronic signature weaknesses is recognizing the symptoms or signals that indicate a potential issue. Common scenarios include:Click to read the full article.

Data Integrity Inspection Findings Linked to Shared User Accounts

Regulatory authorities expect high levels of accountability and traceability in data records. The symptoms indicating potential failures in data integrity due to shared user accounts may include:Click to read the…